BackJasper Therapeutics- Warrants (24/09/2026) Overview
Jasper Therapeutics Inc - Warrants (24/09/2026)

Jasper Therapeutics- Warrants (24/09/2026) Return on Equity

Valuation check: JSPRW's ROE is -2165.39%, below the sector sector average of -5.68%.

Get informed when a big investor buys or sells

+ Follow

ROE

-2165.39%

Return on Equity

-2165.39%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Jasper Therapeutics- Warrants (24/09/2026) (JSPRW) FAQ

Jasper Therapeutics- Warrants (24/09/2026) (JSPRW) currently reports a ROE of -2165.39%. That is below the sector sector average of -5.68%. Use the charts on this page to explore Jasper Therapeutics- Warrants (24/09/2026)'s ROE history and peer comparisons.

Jasper Therapeutics- Warrants (24/09/2026)'s ROE of -2165.39% is lower than the its sector sector average of -5.68%. That is roughly 38006.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Jasper Therapeutics- Warrants (24/09/2026)'s current -2165.39% should be judged against industry norms (sector average: -5.68%) and against JSPRW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -2165.39%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Jasper Therapeutics- Warrants (24/09/2026), and consider following JSPRW for alerts when major investors trade the stock.